H2AZ1: A Drug Target / Disease Biomarker (G3015)

H2AZ1: A Drug Target / Disease Biomarker

H2AZ1, also known as 2-[3-(4-Mercaptoethoxy)phenyl]-5-nitro-2,4,6-trioxanone, is a molecules that has been identified as a potential drug target or biomarker. The molecule is derived from the amino acid tryptophan, which is a key component of the protein molecule.

H2AZ1 is a synthesized peptide that has been shown to have a number of unique properties that make it an interesting candidate for drug development. One of the most notable of these properties is its ability to selectively bind to certain proteins, particularly those involved in the regulation of cell growth and differentiation. This property makes H2AZ1 a potentially useful target for drugs that are designed to inhibit the activity of these proteins.

Another property of H2AZ1 that makes it an attractive candidate for drug development is its ability to induce apoptosis in certain cell types. This property is important for the development of drugs that are designed to induce cell death, as it allows researchers to study the mechanisms of cell death and to identify new approaches for the development of cancer therapies.

In addition to its ability to bind to certain proteins and induce apoptosis, H2AZ1 has also been shown to have a number of other unique properties that make it an interesting candidate for drug development. For example, it is highly stable and has a long half-life, which makes it difficult to eliminate from the body. This property makes it an attractive candidate for drugs that are designed to have a long-lasting effect on the body.

Another property of H2AZ1 that makes it an interesting candidate for drug development is its ability to be modified to suit a variety of different applications. This property allows researchers to customize the molecule to suit their specific needs and to test its potential in a variety of different settings.

Overall, H2AZ1 is a molecules that has a number of unique properties that make it an interesting candidate for drug development. Its ability to selectively bind to certain proteins, induce apoptosis, and be modified to suit a variety of different applications make it an attractive candidate for the development of new cancer therapies. Further research is needed to fully understand the potential of H2AZ1 as a drug target or biomarker.

Protein Name: H2A.Z Variant Histone 1

Functions: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in the formation of constitutive heterochromatin. May be required for chromosome segregation during cell division

More Common Targets

H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2